Headlines

GERN

Biotech Most Active Stocks: Geron Corporation (NASDAQ:GERN), Pfizer Inc. (NYSE:PFE), OXiGENE Inc (NASDAQ:OXGN), Gilead Sciences (NASDAQ:GILD)

Kevin Long02 mins

Geron Corporation (NASDAQ:GERN)  got bad news about its key imetelstat drug, as the FDA issued a clinical hold on the treatment for multiple myeloma and essential thrombocythemia. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the…

Read More

Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Chris Lewis02 mins

Geron Corporation (NASDAQ:GERN) said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume…

Read More

Moving Stocks: Geron Corporation (NASDAQ:GERN), Alcatel Lucent SA (ADR) (NYSE:ALU), CenterState Banks, Inc. (NASDAQ:CSFL), Highpower International, Inc. (NASDAQ:HPJ), Ensco plc (NYSE:ESV)

Kristen Barton03 mins

Geron Corp (NASDAQ:GERN) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $160 thousand versus the consensus estimate of $240 thousand. The company also announced that the U.S. Food and Drug Administration (FDA) has removed the full clinical hold on Geron’s investigational new drug (IND)…

Read More
Home